RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Avecho Biotechnology Stock

Avecho Biotechnology Stocks 2024

Avecho Biotechnology Stocks

2.27 B

Ticker

AVE.AX

ISIN

AU0000047441

WKN

A2PLEV

In 2024, Avecho Biotechnology had 2.27 B outstanding stocks, a 23.41% change from the 1.84 B stocks in the previous year.

The Avecho Biotechnology Stocks history

YEARNUMBER OF STOCKS (undefined AUD)
20232.27
20221.84
20211.8
20201.59
20191.58
20181.57
20171.3
20161.29
20151.29
20141.15
20131.04
20121.04
20110.87
20100.76
20090.7
20080.66
20070.62
20060.56
20050.52
20040.18

Avecho Biotechnology shares outstanding

The number of shares was Avecho Biotechnology in 2023 — This indicates how many shares 2.268 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Avecho Biotechnology earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Avecho Biotechnology's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Avecho Biotechnology’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Avecho Biotechnology's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Avecho Biotechnology Aktienanalyse

What does Avecho Biotechnology do?

Avecho Biotechnology Ltd is a company specializing in the research of technologies to make active ingredients in the cosmetics industry more effective. The company was founded in 2008 by Dr. Timo Roiko-Jokela and is headquartered in Oxfordshire, England. Avecho's business model is based on the innovation of active ingredient technologies. The company has developed a unique technology called Invisicare® that is able to release active ingredients over a longer period of time, resulting in higher effectiveness in application. This technology also allows for better transportation of the active ingredients through the skin while protecting the skin barrier. Avecho Biotechnology has various divisions that focus on different areas of the cosmetics industry, including skincare, sunscreens, haircare, oral care, and body care. Within these divisions, the company offers various products based on the Invisicare® technology, including creamy lotions, serums, sunscreens, and shampoos. One example product from Avecho is the SolarCare range of sun care products, which are able to protect the skin from the harmful effects of UV rays while moisturizing the skin. Another example is the SkinPep range, which is specifically tailored to the needs of the skin and has high effectiveness due to its unique formula and technology. Avecho's innovations and products are utilized by a variety of cosmetics companies and brands. The company works closely with its customers to develop customized products that are tailored to their individual requirements. In recent times, Avecho has expanded its research and development efforts in the field of dermatology. The company is working to find innovative solutions for skin conditions such as psoriasis, eczema, and acne. The Invisicare® technology from Avecho is a key element in improving the effectiveness of active ingredients and protecting the skin barrier. Overall, Avecho Biotechnology is an innovative company specializing in the development of technologies and products in the cosmetics and dermatology industry. With its unique Invisicare® technology, the company provides customized solutions for the individual needs of its customers. Avecho Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Avecho Biotechnology's Shares Outstanding

Avecho Biotechnology's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Avecho Biotechnology’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Avecho Biotechnology’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Avecho Biotechnology’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Avecho Biotechnology stock

How many stocks are there of Avecho Biotechnology?

The current number of stocks of Avecho Biotechnology is 2.27 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Avecho Biotechnology are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Avecho Biotechnology evolved in recent years?

The number of shares of Avecho Biotechnology has increased by 23.41% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Avecho Biotechnology as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Avecho Biotechnology?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Avecho Biotechnology pay?

Over the past 12 months, Avecho Biotechnology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Avecho Biotechnology is expected to pay a dividend of 0 AUD.

What is the dividend yield of Avecho Biotechnology?

The current dividend yield of Avecho Biotechnology is .

When does Avecho Biotechnology pay dividends?

Avecho Biotechnology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Avecho Biotechnology?

Avecho Biotechnology paid dividends every year for the past 0 years.

What is the dividend of Avecho Biotechnology?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Avecho Biotechnology located?

Avecho Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Avecho Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Avecho Biotechnology from 6/6/1997 amounting to 0.02 AUD, you needed to have the stock in your portfolio before the ex-date on 5/14/1997.

When did Avecho Biotechnology pay the last dividend?

The last dividend was paid out on 6/6/1997.

What was the dividend of Avecho Biotechnology in the year 2023?

In the year 2023, Avecho Biotechnology distributed 0 AUD as dividends.

In which currency does Avecho Biotechnology pay out the dividend?

The dividends of Avecho Biotechnology are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Avecho Biotechnology

Our stock analysis for Avecho Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Avecho Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.